Clinical Trial News & New Online Survey
Posted on October 20, 2022
PTC Therapeutics provides enrollment update PTC Therapeutics shared a press release this week to confirm that enrollment is active and…
Read MoreHDSA Surveys & Support the HD Parity Act!
Posted on October 13, 2022
Participate in HDSA-Vetted Research Surveys Researchers, clinicians, healthcare professionals, and students studying HD frequently design surveys to get input from…
Read MoreThis Week’s Blog: 10.6.2022
Posted on October 6, 2022
HDBuzz on ASO headlines: What’s the latest on huntingtin-lowering? Recent weeks have brought news for familiar players in the…
Read MoreHD Buzz: Real talk with Roche on GENERATION-HD1
Posted on September 30, 2021
The editors of HD Buzz recently sat down with leaders from Roche to ask questions on behalf of the HD community…
Read MoreNew Biomarkers to Track Disease-Modifying Therapies in Pre-manifest HD
Posted on July 15, 2021
Much of today’s efforts in HD research are focused on lowering huntingtin protein in early stages of the disease. Ideally, clinicians could begin…
Read More